20% quarter-over-quarter revenue growth to $3.3 million

Recent real-world health economic data for all three of Pear’s commercial products show cost-savings1-3

Recent commercial formulary additions for reSET® and reSET-O®

BOSTON–(BUSINESS WIRE)…